Insights

Innovative Therapeutics Altimmune is developing a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors, addressing serious liver diseases such as MASH, AUD, and ALD. This presents opportunities to collaborate with healthcare providers and clinics focusing on metabolic and liver disorders.

Recent Funding Boost The company secured a substantial $100 million credit facility from Hercules Capital, significantly extending its development runway for key drugs like pemvidutide. This financial stability indicates a strong foundation for potential partnership and investment opportunities.

Research and Events Altimmune actively participates in major medical events like The Liver Meeting and American Diabetes Association sessions, showcasing their clinical data. Engaging with their presentation audiences provides a chance for targeted outreach to researchers and healthcare professionals interested in liver and metabolic treatments.

Market Challenges Recent legal issues including class action lawsuits and allegations of securities violations may impact their market perception. Monitoring these developments could identify opportunities to offer compliance, legal advisory, or risk mitigation services.

Growth Potential Although currently with low revenue, Altimmune’s focus on late-stage clinical trials and substantial funding indicate potential for significant growth and market entry, making them a strategic partner for biotech investments, licensing agreements, or distribution collaborations.

Altimmune, Inc. Tech Stack

Altimmune, Inc. uses 8 technology products and services including Veeva Vault, Deltek, Bunny Fonts, and more. Explore Altimmune, Inc.'s tech stack below.

Veeva Vault

Enterprise Content Management

Deltek

Enterprise Resource Planning

Bunny Fonts

Font Scripts

Web Vitals

Javascript Libraries

DocuSign

Miscellaneous

Smartsheet

Project Management

X-XSS-Protection

Security

Adobe Creative Suite

Visualisation Software

Altimmune, Inc. Email Formats	Example	Percentage
FLast@altimmune.com	JDoe@altimmune.com	88%
First.Last@altimmune.com	John.Doe@altimmune.com	6%
Last@altimmune.com	Doe@altimmune.com	4%
LastF@altimmune.com	DoeJ@altimmune.com	2%

Altimmune, Inc. Email Formats

Example

Percentage

FLast@altimmune.com

JDoe@altimmune.com

88%

First.Last@altimmune.com

John.Doe@altimmune.com

Last@altimmune.com

Doe@altimmune.com

LastF@altimmune.com

DoeJ@altimmune.com

Frequently Asked Questions

Where is Altimmune, Inc.'s headquarters located?

Altimmune, Inc.'s main headquarters is located at 910 Clopper Road Gaithersburg, Maryland 20878 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Altimmune, Inc.'s phone number?

You can contact Altimmune, Inc.'s main corporate office by phone at

+1-240-654-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Altimmune, Inc.'s official website and social media links?

Altimmune, Inc.'s official website is altimmune.com and has social profiles on LinkedIn.

What is Altimmune, Inc.'s SIC code NAICS code?

Altimmune, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Altimmune, Inc. have currently?

As of May 2026, Altimmune, Inc. has approximately 83 employees across 2 continents, including North AmericaEurope. Key team members include Chief Commercial Officer: L. R.Chief Medical Officer: C. A.Chief Legal Officer And Corporate Secretary: R. A.. Explore Altimmune, Inc.'s employee directory with LeadIQ.

What industry does Altimmune, Inc. belong to?

Altimmune, Inc. operates in the Biotechnology Research industry.

What technology does Altimmune, Inc. use?

Altimmune, Inc.'s tech stack includes Veeva VaultDeltekBunny FontsWeb VitalsDocuSignSmartsheetX-XSS-ProtectionAdobe Creative Suite.

What is Altimmune, Inc.'s email format?

Altimmune, Inc.'s email format typically follows the pattern of FLast@altimmune.com. Find more Altimmune, Inc. email formats with LeadIQ.

When was Altimmune, Inc. founded?

Altimmune, Inc. was founded in 1997.

Altimmune, Inc.

Q: What is Altimmune, Inc.'s official website and social media links?

Altimmune, Inc.'s official website is altimmune.com. Altimmune, Inc. has social profiles on LinkedIn.

Q: How many employees does Altimmune, Inc. have currently?

Altimmune, Inc. has approximately 83 employees.

Q: What technology does Altimmune, Inc. use?

Altimmune, Inc.'s tech stack includes Microsoft, Underscore.js, YouTube, Deltek, Drupal.

Q: What is Altimmune, Inc.'s NAICS code?

Altimmune, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMaryland, United States51-200 Employees

Altimmune is a late clinical-stage biopharmaceutical company developing therapies to improve the lives of people living with serious liver diseases.

Our lead program is a differentiated dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio, currently in development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD).

#ClinicalResearch #LiverCare #BioResearch

Insights

Similar companies to Altimmune, Inc.

Novavax

Immatics

Moderna

Emergent BioSolutions

Dynavax Technologies

Gritstone bio

Altimmune, Inc. Tech Stack

Media & News

Altimmune, Inc. expanded offices to New Jersey, United States, Northern America, Americas on Jun 17th '26.

Brown leaves Altimmune, Inc. as Chief Financial Officer.

Altimmune, Inc. attends event The Liver Meeting(R) 2025.

Altimmune, Inc. has issues with Class Action lawsuit.

Altimmune, Inc. has issues with securities fraud or other unlawful business practices.

Altimmune, Inc. had issues with alleged securities violations on Jun 26th '25.

Altimmune, Inc. attends event 85th Scientific Sessions.

Altimmune, Inc.'s Email Address Formats